Sao Paulo State University

About: Sao Paulo State University is a education organization based out in São Paulo, Brazil. It is known for research contribution in the topics: Population & Large Hadron Collider. The organization has 55715 authors who have published 100436 publications receiving 1375332 citations.

Pectin and Pectinases: Production, Characterization and Industrial Application of Microbial Pectinolytic Enzymes

Abstract: Departamento de Bioquimica e Microbiologia Instituto de Biociencias Universidade Estadual Paulista, UNESP, Avenida 24A, 1515, CEP 13506-900 Rio Claro, SP

Diversidade da ictiofauna do Alto Rio Paraná: composição atual e perspectivas futuras

Abstract: Langeani, F., Castro, R.M.C., Oyakawa, O.T., Shibatta, O.A., Pavanelli, C.S. & Casatti, L. Ichthyofauna diversity of the upper rio Parana: present composition and future perspectives. Biota Neotrop. Sep/Dez 2007 vol. 7, no. 3 http://www.biotaneotropica.org.br/v7n3/pt/abstract?article+bn03407032007. ISSN 1676-0603. A synthesis concerning fishes from Upper Parana River basin is presented, based on data from fish-collections, literature, and new field samples. Three hundred and ten species, pertaining to 11 orders and 38 families, are referred to the drainage, elevating anterior estimates. Concerning total species, 236 (76.1%) are autochthonous, 67 (21.6%) are allochthonous, and seven (2.3%) are exotic. Principal causes of occurrence of non-native species are: a) dispersal from the Lower Parana, after the construction of Itaipu dam, and b) escapes from aquaculture farms. Most species (65%) are small-sized, having less than 21 cm of length, and the great majority occurs only in headwaters and small streams. One of the best known and most studied in Brazil, Upper Parana ichthyofauna richness is far from reaching actual numbers, considering the exponential elevation of species presented herein. Indeed, in the last years various new species have been described and around 50 other species, already recognized as new, are now under description. The improvement on the knowledge about Upper Parana ichthyofauna is proportional to the number of researchers involved with studies in the area and, unequivocally, reflects recent initiatives stimulating and incrementing taxonomic research, and also improving access to fish collections and to poor or never-sampled areas. However, if we are going to maintain the number of species descriptions per year of last decade, the 50 new species already recognized, will be described only in the next ten years, a period too long. In consequence it is very important that scientific community and grant agencies find and offer initiatives in order to elevate the number of new taxa descriptions per year.

Antifungal Therapy: New Advances in the Understanding and Treatment of Mycosis.

Abstract: The high rates of morbidity and mortality caused by fungal infections are associated with the current limited antifungal arsenal and the high toxicity of the compounds. Additionally, identifying novel drug targets is challenging because there are many similarities between fungal and human cells. The most common antifungal targets include fungal RNA synthesis and cell wall and membrane components, though new antifungal targets are being investigated. Nonetheless, fungi have developed resistance mechanisms, such as overexpression of efflux pump proteins and biofilm formation, emphasizing the importance of understanding these mechanisms. To address these problems, different approaches to preventing and treating fungal diseases are described in this review, with a focus on the resistance mechanisms of fungi, with the goal of developing efficient strategies to overcoming and preventing resistance as well as new advances in antifungal therapy. Due to the limited antifungal arsenal, researchers have sought to improve treatment via different approaches, and the synergistic effect obtained by the combination of antifungals contributes to reducing toxicity and could be an alternative for treatment. Another important issue is the development of new formulations for antifungal agents, and interest in nanoparticles as new types of carriers of antifungal drugs has increased. In addition, modifications to the chemical structures of traditional antifungals have improved their activity and pharmacokinetic parameters. Moreover, a different approach to preventing and treating fungal diseases is immunotherapy, which involves different mechanisms, such as vaccines, activation of the immune response and inducing the production of host antimicrobial molecules. Finally, the use of a mini-host has been encouraging for in vivo testing because these animal models demonstrate a good correlation with the mammalian model; they also increase the speediness of as well as facilitate the preliminary testing of new antifungal agents. In general, many years are required from discovery of a new antifungal to clinical use. However, the development of new antifungal strategies will reduce the therapeutic time and/or increase the quality of life of patients.

‘Candidatus Liberibacter americanus’, associated with citrus huanglongbing (greening disease) in São Paulo State, Brazil

Abstract: Full Text (PDF) Supplementary Table Alert me when this article is cited Alert me if a correction is posted Citation Map ABSTRACT TOP ABSTRACT MAIN TEXT REFERENCES Symptoms of huanglongbing (HLB) were reported in Sao Paulo State (SPS), Brazil, in March 2004. In Asia, HLB is caused by 'Candidatus Liberibacter asiaticus' and in Africa by 'Candidatus Liberibacter africanus'. Detection of the liberibacters is based on PCR amplification of their 16S rRNA gene with specific primers. Leaves with blotchy mottle symptoms characteristic of HLB were sampled in several farms of SPS and tested for the presence of liberibacters. 'Ca. L. asiaticus' was detected in a small number of samples but most samples gave negative PCR results. Therefore, a new HLB pathogen was suspected. Evidence for an SPS-HLB bacterium in symptomatic leaves was obtained by PCR amplification with universal primers for prokaryotic 16S rRNA gene sequences. The amplified 16S rRNA gene was cloned and sequenced. Sequence analysis and phylogeny studies showed that the 16S rRNA gene possessed the oligonucleotide signatures and the secondary loop structure characteristic of the -Proteobacteria, including the liberibacters. The 16S rRNA gene sequence phylogenetic tree showed that the SPS-HLB bacterium clustered within the -Proteobacteria, the liberibacters being its closest relatives. For these reasons, the SPS-HLB bacterium is considered a member of the genus 'Ca. Liberibacter'. However, while the 16S rRNA gene sequences of 'Ca. L. asiaticus' and 'Ca. L. africanus' had 98·4 % similarity, the 16S rRNA gene sequence of the SPS- HLB liberibacter had only 96·0 % similarity with the 16S rRNA gene sequences of 'Ca. L. asiaticus' or 'Ca. L. africanus'. This lower similarity was reflected in the phylogenetic tree, where the SPS-HLB liberibacter did not cluster within the 'Ca. L asiaticus'/'Ca. L. africanus group', but as a separate branch. Within the genus 'Candidatus Liberibacter' and for a given species, the 16S/23S intergenic region does not vary greatly. The intergenic regions of three strains of 'Ca. L. asiaticus', from India, the People's Republic of China and Japan, were found to have identical or almost identical sequences. In contrast, the intergenic regions of the SPS-HLB liberibacter, 'Ca. L. asiaticus' and 'Ca. L. africanus' had quite different sequences, with similarity between 66·0 and 79·5 %. These results confirm that the SPS-HLB liberibacter is a novel species for which the name 'Candidatus Liberibacter americanus' is proposed. Like the